Stem cell collection and gene transfer in Fanconi anemia (Q40260881)

19 September 2017

Stem cell collection and gene transfer in Fanconi anemia (English)

1 reference

19 September 2017

3

Christof von Kalle

0 references

Arleen D. Auerbach

object named as

Arleen D Auerbach

13

0 references

author name string

Patrick F Kelly

1

1 reference

19 September 2017

Susan Radtke

2

1 reference

19 September 2017

Brenden Balcik

4

1 reference

19 September 2017

Kimberley Bohn

5

1 reference

19 September 2017

Robin Mueller

6

1 reference

19 September 2017

Todd Schuesler

7

1 reference

19 September 2017

Moira Haren

8

1 reference

19 September 2017

Lilith Reeves

9

1 reference

19 September 2017

Jose A Cancelas

10

1 reference

19 September 2017

Thomas Leemhuis

11

1 reference

19 September 2017

Richard Harris

12

1 reference

19 September 2017

Franklin O Smith

14

1 reference

19 September 2017

Stella M Davies

15

1 reference

19 September 2017

David A Williams

16

1 reference

19 September 2017

language of work or name

1 reference

1 January 2007

1 reference

19 September 2017

1 reference

19 September 2017

15

1 reference

19 September 2017

211-219

1 reference

19 September 2017

1

1 reference

Molecular pathogenesis of Fanconi anemia: recent progress

19 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi Anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Correction of Fanconi anemia type C phenotypic abnormalities using a clinically suitable retroviral vector infection protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Natural gene therapy in monozygotic twins with Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Genetic basis of Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

The Fanconi Anemia/BRCA pathway: new faces in the crowd

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

A component of the chloroplast protein import apparatus functions in bacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Tumor necrosis factor-alpha overproduction in Fanconi's anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Modulation of hematopoietic stem cell homing and engraftment by CD26

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Molecular interactions involved in HOXB4-induced activation of HSC self-renewal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Retroviral pseudotransduction for targeted cell manipulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300033

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300033

1 reference

19 September 2017

1 reference